NeurologyLive® Friday 5 — May 19, 2023

Article

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending May 19, 2023.

Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Cure Connection: Advice for Physicians and the Multiple Sclerosis Community

In episode 10 of this Cure Connection series on "The Patient Journey in the Management of Multiple Sclerosis," a panel shares final advice for the multiple sclerosis community.

Advice for Physicians and the Multiple Sclerosis Community

2: Peer Exchange: Pitolisant Efficacy and Safety

In episode 10 of this Peer Exchange series on "Advances in the Management of Excessive Daytime Sleepiness and Narcolepsy", Anne Marie Morse, DO, FAASM, discusses the efficacy and safety profile of pitolisant for the treatment of narcolepsy.

Pitolisant Efficacy and Safety

3: NeuroVoices: Nancy Foldvary-Schaefer, DO, FAAN, on the Crossover Between Sleep and Epilepsy

In the latest edition of our in-depth Q&A series, the director of the Sleep Disorders Center and staff in the Epilepsy Center at Cleveland Clinic provided perspective on the current state of sleep and epilepsy research, including the role of postical generalized EEG suppression as a biomarker for SUDEP.

NeuroVoices: Nancy Foldvary-Schaefer, DO, FAAN, on the Crossover Between Sleep and Epilepsy

4: Potential for Preventing NMOSD, Improving Access to Panel Testing: Sean Pittock, MD

The director of the Mayo Clinic Center for Multiple Sclerosis and Autoimmune Neurology provided commentary on the possibility of preventing NMOSD, and the need to improve access to approved therapies and AQP4 testing. [WATCH TIME: 3 minutes]

Potential for Preventing NMOSD, Improving Access to Panel Testing: Sean Pittock, MD

5: Neurology News Network: Implementing NfL in MS in Clinical Practice

In this episode 3 of this Neurology News Network series on "AAN 2023: Neurofilament Light Chain and Disease Progression in Multiple Sclerosis", an expert neurologist discusses pNfL being utilized outside of clinical trials and implemented into clinical practice for the treatment of MS.

Implementing NfL in MS in Clinical Practice
Related Videos
Monica Verduzco-Gutierrez, MD
Shahid Nimjee, MD, PhD
Peter J. McAllister, MD, FAAN
Video 6 - "Utilization of Neuroimaging in Alzheimer’s Disease"
Video 5 - "Contribution of Multiple Pathways to the Development of Alzheimer’s Disease"
Michael Levy, MD, PhD
Michael Levy, MD, PhD
© 2024 MJH Life Sciences

All rights reserved.